MSI-HIGH
Clinical trials for MSI-HIGH explained in plain language.
Never miss a new study
Get alerted when new MSI-HIGH trials appear
Sign up with your email to follow new studies for MSI-HIGH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested to boost cancer immunotherapy
Disease control Recruiting nowThis study is testing a new oral medication called Alintegimod, given alongside the immunotherapy drugs ipilimumab and nivolumab. It aims to see if this combination is safe and can help control advanced cancers that have spread or returned after other treatments. The study will e…
Matched conditions: MSI-HIGH
Phase: PHASE1, PHASE2 • Sponsor: 7 Hills Pharma, LLC • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Radioactive 'Seeker' drug targets advanced cancers in first human test
Disease control Recruiting nowThis is a very early, first-in-human study to test the safety and find the right dose of a new radioactive drug called 177Lu-RAD204. It is for adults with advanced solid tumors (like lung, breast, or skin cancer) that have spread and have stopped responding to standard treatments…
Matched conditions: MSI-HIGH
Phase: EARLY_PHASE1 • Sponsor: Radiopharm Theranostics, Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC